Menu

BeiGene, Ltd. BGNE

Full chart Compare
Set alert

Price alert · BGNE

All alert types
184.71 0.00 (+0.00%)

At closeDec 31, 2024, 4:00 PM EST

183.91 Day range 187.42

52-week range unavailable

YTD
+4.67%
1 year
+4.67%

Revenue & Expenses

Other Income → Expenses: $307.89MExpenses → Selling, General & Admin: $1.50BExpenses → Research & Development: $1.78BExpenses → Other Operating Expenses: $3.50MExpenses → Income Tax: $55.87MGross Profit → Expenses: $2.08BRevenue → Gross Profit: $2.08BRevenue → Cost of Revenue: $379.92MNet Loss → Expenses: $881.71MOther Income$307.89MGross Profit$2.08BNet Loss$881.71MCost of Revenue$379.92MExpenses$3.27BSelling, General & Admin$1.50BResearch & Development$1.78BOther Operating Expenses$3.50MIncome Tax$55.87MRevenue$2.46B

Latest period ending Dec 31, 2023 · select a line to chart its full history

BGNE annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
2.46B1.42B1.18B308.87M428.21M
2.08B1.13B1.01B238.22M357.02M
-1.21B-1.79B-1.44B-1.66B-959.89M
-881.71M-2.00B-1.46B-1.62B-948.63M
-0.65-1.49-1.21-1.50-1.22
BGNE annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
3.17B3.87B4.38B1.38B618.30M
5.81B6.38B8.54B5.60B1.61B
2.27B2.00B2.40B1.73B633.93M
930.18M596.67M694.64M561.96M277.34M
3.54B4.38B6.13B3.87B962.21M
BGNE annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
-1.16B-1.50B-1.30B-1.28B-750.27M
60.00M1.08B640.66M-3.17B554.16M
416.48M-18.97M3.64B5.20B85.68M
-561.90M-325.43M-262.94M-117.51M-89.61M
-689.05M-507.85M2.99B769.23M-119.94M